| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.092 | 0.07 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.51 | 0.07 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.08 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |